A. Nattermann & Cie Gmbh

Troponwerke Gmbh & Co Kg

Bayer Aktiengesellschaft

Nattermann & Cie Gmbh

Eugen Etschenberg

Wolfgang Opitz

Andre Welter

Sigurd Leyck

Haireddin Jacobi

Miklos Ghyczy

Siegfried Raddatz

Adorjan Erdos

Johannes Winkelmann

Gotz Ritzmann

Norbert Dereu

Jorg Traber

Kurt H Bauer

Hans-Heiner Lautenschlager

Karl-Heinz Boltze

Jurgen Biedermann

Hans-Dieter Dell

Erich Graf

Albrecht Wendel

Hugo Friehe

Leon Christiaens

Meinhard Zenk

Wolfgang Scheef

Heinrich Osthoff

Herbert Busgen

Andrea Huther

Christian Lambert

Harmut Fischer

Peter Kuhl

Marcel Renson

Eric Graf

The present invention relates to new diselenobis-benzoic acid amides of primary and secondary amines of the general formula (I): ##STR1## and processes for the treatment of diseases in humans caused by a cell injury.

Diselenobis-benzoic acid amides of primary and secondary amines and

The present invention relates to new benzisoselenazolonyl derivatives of the general formula (I) ##STR1## and processes for the treatment of rheumatic diseases.

Benzisoselenazolonyl derivatives and processes for the treatment of

The invention relates to new benzisoselenazolethiones of the general formula I ##STR1## and to processes for the treatment of various diseases by administering them to such beings.

Benzisoselenazolethiones and process for the treatment of various

The present invention relates to novel benzodiazepines, acid addition salts thereof, processes for their preparation and their use in combating diseases, in particular for the treatment of cerebral disorders caused by old age and for the treatment of disorders in learning and memory and amnesia.

New benzodiazepines and their use

New foliage fertilizers containing one or more macronutrients and/or one or more micronutrients as well as 10 to 50% by weight (referred to total nutrients) of one or more phospholipids.

Foliage fertilizers

The invention relates to new benzisoselenazolones of the general formula I ##STR1## and a process for the treatment of humans suffering from inflammatory diseases of the rheumatic type.

Benzisoselenazolones and a process for the treatment of inflammatory

The invention relates to the new optically active dipeptide D-2-phenylglycyl-D-2-phenylglycine and its pharmacologically acceptable salts or acid addition salts and the use thereof as tissue dissolving and histolytic agent.

Optically active dipeptides and the use thereof as tissue dissolving and

The invention relates to new benzisoselenazolones of the general formula I ##STR1## and to the use thereof in the treatment of inflammatory diseases in humans.

Cycloalkyl derivatives of benzisoselenazolones

The invention relates to the new use of certain benzisothiazoles corresponding to the following general formula: ##STR1## wherein R.sub.1 represents chlorine, fluorine or bromine, and R.sub.2 represents hydrogen, chlorine, fluorine or bromine, in the treatment of phlogistic and/or arteriosclerotic processes.

Treatment of rheumatism and arteriosclerosis with

The present invention is related to pharmaceutical preparations containing as active components the known compound 2-phenyl-1.2-benzisoselenazol-3(2H)-one containing pharmaceutical preparations and process for the treatment in particular of rheumatic diseases.

2-Phenyl-1,2-benzisoselenazol-3(2H)-one containing pharmaceutical

The invention relates to pharmaceutical compositions containing as an active ingredient a dipeptide or an acid salt or a base addition salt thereof or a stereoisomer thereof, said dipeptide being those of the formula

Histolytic agents and their use

The invention relates to compositions containing S-benzyl 3-benzylthiopropionothioate for the treatment of inflammatory processes. Also included in the invention are methods for combating illnesses caused by inflammatory, processes, which methods involve use of medicaments containing said S-benzyl 3-benzylthiopropionothioate.

Antiphlogistic agent and its use

The present invention is directed to a new process for the treatment of inflammatory diseases and disorders in humans by administering a pharmaceutical preparation containing rosmarinic acid.

Use of rosmarinic acid in the treatment of inflammations and

Dehydrooligopeptides, some of which are known, demonstrate histolytic and tumor-resolving activity and may be used in medicaments causing the lysis of animal tissues and/or tumors in warm-blooded animals.

Tumor-resolving and histolytic medicaments and their use

Solutions of anti-inflammatory acrylacetic and arylpropionic acid derivatives are stabilized by addition of phospholipids. The solutions are suitable for parenteral administration; they are well tolerated and have a long-lasting action.

Growing community of inventors

Cologne, Germany

Eugen Etschenberg